SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001206774-15-001134
Filing Date
2015-04-03
Accepted
2015-04-03 16:30:43
Documents
7
Period of Report
2015-05-18
Effectiveness Date
2015-04-03

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY SATEMENT geron_def14a.htm DEF 14A 721222
2 GRAPHIC geron_def14a1x1x1.jpg GRAPHIC 4273
3 GRAPHIC geron_def14a1x1x2.jpg GRAPHIC 9019
4 GRAPHIC geron_def14a1x2x1.jpg GRAPHIC 7780
5 GRAPHIC geron_def14a5x11x1.jpg GRAPHIC 8998
6 GRAPHIC geron_def14a5x12x1.jpg GRAPHIC 13235
7 GRAPHIC geron_def14ax2x1.jpg GRAPHIC 5818
  Complete submission text file 0001206774-15-001134.txt   790999
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

IRS No.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-20859 | Film No.: 15751581
SIC: 2834 Pharmaceutical Preparations